Al-Driven Crypto Investment Research Revolution
Ethzilla
$2.310-4.55%
ETHZETH TreasuryNASDAQ
Value Traded$18,504,052
Total Market Cap$400,458,345
Circulating Market Cap$339,299,534
Turnover rate5.63%
Scan QR Code to Explore more key information
$2.310-4.55%Close 09/05 16:00 EST
Post Market$2.320+0.43%09/05 16:50 EST
Value Traded$18,504,052
Volume7,899,177
Turnover rate5.63%
High$2.540
Low$2.221
Total Market Cap$400,458,345
Circulating Market Cap$339,299,534
Total Shares165,478,655
Circulating Shares140,206,419
PE TTM-0.16
PB73.33

Info

ETHZilla Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palm Beach, FL.
Listing Date2017-06-27
SectorETH Treasury
ExchangeNASDAQ
Website180lifesciences.com
Social Mediatwitter